braindisorders 2021 June 28-30 2020

The World Congress on Advances in Brain injury, Disorders and Therapeutics would be a stage for interconnecting National and Global specialists, scientists and chiefs both from the scholarly world and industry from everywhere throughout the world to trade their insight, skill and research developments in the field of Brain issue, Neurology and Therapeutics. These Brain Issue and Neurology meeting is a station for trading thought and learning on Cerebrum damage, brain tumor, brain Issue, Neurology, Neuroscience, Neuroimaging, and Neurological issue. This conference includes the investigation identified with the conclusion and treatment of infection or failing of the cerebrum, muscles, fringe nerves, spinal cord, and autonomic sensory system. The target of the gathering is to keep up and create science and related research at a universal level. To accomplish this, it is vital to carry into a significant field of neurology with the novel investigations, which can spare a huge number of lives we Navigating the Future Advancements in Brain Therapeutics.

Track 1: Brain Injury

A Brain injury is any sort of injury to your brain, skull, or scalp. This can range from a mild bump or bruise to a traumatic brain injury. Common head injuries include concussions, skull fractures, and scalp wounds. The consequences and treatments vary greatly, depending on what caused your head injury and how severe it is. Brain injuries may be either closed or open. A closed head injury is an injury that doesn’t break your skull. An open (penetrating) head injury is one in which something breaks your scalp and skull and enters your brain. It can be hard to assess how serious a head injury is just by looking. Some minor head injuries bleed a lot, while some major injuries don’t bleed at all

Cognitive Science Conferences | Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Brain Conferences

8th International Conference on Cognitive Science, Brain Disorders and Research, September 21-22, 2018 Philadelphia, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan, 6^th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark | 26^th European Neurology Congress; August 6-8, 2018; Madrid, Spain  | 4^th International Conference on Epilepsy & Treatment; August 29-30, 2018; Zurich, Switzerland |19^th Congress of the International Headache Society September 6-9, 2018; Dublin, Ireland | 22^nd International Congress of Parkinson's Disease and Movement Disorders; October 5-9, 2018; Hong Kong.

Track 2: Brain Disorders and Pathophysiology

A neurological issue is any disorder of the sensory system. Auxiliary, biochemical or electrical variations from the norm in the mind, spinal line or different nerves can bring about the scope of manifestations. Cases of side effects incorporate loss of motion, muscle shortcoming, poor coordination, loss of sensation, seizures, perplexity, torment and modified levels of awareness. There are numerous perceived neurological issue, some moderately normal, however numerous uncommon. They might be evaluated by neurological examination and contemplated and treated inside the specialties of neurology and clinical neuropsychology

Cognitive Science Conferences | Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Brain Conferences

8th International Conference on Cognitive Science, Brain Disorders and Research, September 21-22, 2018 Philadelphia, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan, 6^th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark | 26^th European Neurology Congress; August 6-8, 2018; Madrid, Spain  | 4^th International Conference on Epilepsy & Treatment; August 29-30, 2018; Zurich, Switzerland |19^th Congress of the International Headache Society September 6-9, 2018; Dublin, Ireland | 22^nd International Congress of Parkinson's Disease and Movement Disorders; October 5-9, 2018; Hong Kong.

Track 3: Brain Complication

A Brain Injury is an injury that results in trauma to the skull or brain. The terms traumatic brain injury and head injury are often used interchangeably in the medical literature. This broad classification includes neuronal injuries, hemorrhages, vascular injuries, cranial nerve injuries, and subdural hygromas, among many others. These classifications can be further categorized as open (penetrating) or closed head injuries

Cognitive Science Conferences | Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Brain Conferences

8th International Conference on Cognitive Science, Brain Disorders and Research, September 21-22, 2018 Philadelphia, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan, 6^th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark | 26^th European Neurology Congress; August 6-8, 2018; Madrid, Spain  | 4^th International Conference on Epilepsy & Treatment; August 29-30, 2018; Zurich, Switzerland |19^th Congress of the International Headache Society September 6-9, 2018; Dublin, Ireland | 22^nd International Congress of Parkinson's Disease and Movement Disorders; October 5-9, 2018; Hong Kong.

Track 4: Traumatic Brain Injury

Traumatic brain injury is a degenerative or congenital nature but caused by an external physical force that may produce a diminished or altered state of consciousness, which results in an impairment of cognitive abilities or physical functioning. The disturbances of cognitive, emotional, and behavioral functioning after TBI may produce permanent impairments. There are 3 different types of traumatic brain injury are following Mild traumatic brain injury is a trauma to the head that results in a confused state or a loss of consciousness of fewer than 30 minutes. Moderate traumatic brain injury is a trauma to the head that results in a loss of consciousness of 30 minutes to 24 hours. Severe traumatic brain injury is a trauma to the head that results in a loss of consciousness of greater than 24 hours

Cognitive Science Conferences | Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Brain Conferences

8th International Conference on Cognitive Science, Brain Disorders and Research, September 21-22, 2018 Philadelphia, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan, 6^th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark | 26^th European Neurology Congress; August 6-8, 2018; Madrid, Spain  | 4^th International Conference on Epilepsy & Treatment; August 29-30, 2018; Zurich, Switzerland |19^th Congress of the International Headache Society September 6-9, 2018; Dublin, Ireland | 22^nd International Congress of Parkinson's Disease and Movement Disorders; October 5-9, 2018; Hong Kong.

Track 5: Brain Injury Biomarkers

Brain Injury is usually reliably visible as structural abnormalities using techniques such as computed tomography (CT) or conventional magnetic resonance imaging (MRI), more subtle disturbances characteristic of mild TBI are not so easily demonstrated by these imaging modalities. Mild TBI results from the main etiologist of neural contusion and axonal injury, which subsequently results in biochemical, metabolic, and cellular changes that may be responsible for some of the long-term problems seen in patients who develop Postconcussion syndrome (PCS). Since several if not all imaging modalities employed in TBI diagnosis are dependent on structural of functional rearrangement of cellular or extracellular components or assessment of blood-brain barrier (BBB) disruption, it is not surprising that surrogate peripheral or central nervous system (CNS) correlates of CT or MRI have been described.

Cognitive Science Conferences | Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Brain Conferences

8th International Conference on Cognitive Science, Brain Disorders and Research, September 21-22, 2018 Philadelphia, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan, 6^th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark | 26^th European Neurology Congress; August 6-8, 2018; Madrid, Spain  | 4^th International Conference on Epilepsy & Treatment; August 29-30, 2018; Zurich, Switzerland |19^th Congress of the International Headache Society September 6-9, 2018; Dublin, Ireland | 22^nd International Congress of Parkinson's Disease and Movement Disorders; October 5-9, 2018; Hong Kong.

Track 6: Brain Stem Stroke

A stroke occurs when the blood supply to the brain is interrupted. The way a stroke affects the brain depends on which part of the brain suffers damage. Brain stem strokes can have complex symptoms, and they can be difficult to diagnose. Brain stem strokes can have complex symptoms, and they can be difficult to diagnose. If a stroke in the brain stem results from a clot, the faster blood flow can be restored in this critical area, the better the chances for recovery. The risk factors for brain stem stroke are the same as for stroke in other areas of the brain: high blood pressure, diabetes, heart disease, atrial fibrillation, and smoking. Like strokes in other areas of the brain, brain stem strokes can be caused by a clot or a hemorrhage. There are also rare causes, like the injury to an artery due to sudden head or neck movements

Cognitive Science Conferences | Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Brain Conferences

8th International Conference on Cognitive Science, Brain Disorders and Research, September 21-22, 2018 Philadelphia, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan, 6^th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark | 26^th European Neurology Congress; August 6-8, 2018; Madrid, Spain  | 4^th International Conference on Epilepsy & Treatment; August 29-30, 2018; Zurich, Switzerland |19^th Congress of the International Headache Society September 6-9, 2018; Dublin, Ireland | 22^nd International Congress of Parkinson's Disease and Movement Disorders; October 5-9, 2018; Hong Kong.

Track 7: Neurodegenerative Diseases and Management

Neurodegeneration is the progressive loss of structure or function of neurons, including the death of neurons. Many neurodegenerative diseases occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells. As research progresses, many similarities appear that relate these diseases to one another on a sub-cellular level. Discovering these similarities offers hope for therapeutic advances that could ameliorate many diseases simultaneously. There are many parallels between different neurodegenerative disorders including atypical protein assemblies as well as induced cell death. Neurodegeneration can be found in many different levels of neuronal circuitry ranging from molecular to systemic.

Cognitive Science Conferences | Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Brain Conferences

8th International Conference on Cognitive Science, Brain Disorders and Research, September 21-22, 2018 Philadelphia, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan, 6^th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark | 26^th European Neurology Congress; August 6-8, 2018; Madrid, Spain  | 4^th International Conference on Epilepsy & Treatment; August 29-30, 2018; Zurich, Switzerland |19^th Congress of the International Headache Society September 6-9, 2018; Dublin, Ireland | 22^nd International Congress of Parkinson's Disease and Movement Disorders; October 5-9, 2018; Hong Kong.

Track 8: Brain Stimulation Therapies

Brain stimulation therapies can play a role in treating certain mental disorders. Brain stimulation therapies involve activating or inhibiting the brain directly with electricity. The electricity can be given directly by electrodes implanted in the brain, or noninvasively through electrodes placed on the scalp. The electricity can also be induced by using magnetic fields applied to the head. While these types of therapies are less frequently used than medication and psychotherapies, they hold promise for treating certain mental disorders that do not respond to other treatments

Cognitive Science Conferences | Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Brain Conferences

8th International Conference on Cognitive Science, Brain Disorders and Research, September 21-22, 2018 Philadelphia, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan, 6^th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark | 26^th European Neurology Congress; August 6-8, 2018; Madrid, Spain  | 4^th International Conference on Epilepsy & Treatment; August 29-30, 2018; Zurich, Switzerland |19^th Congress of the International Headache Society September 6-9, 2018; Dublin, Ireland | 22^nd International Congress of Parkinson's Disease and Movement Disorders; October 5-9, 2018; Hong Kong.

Track 9: Alzheimer’s Disease & Dementia

Alzheimer’s is one of the most common causes of dementia among older adults. Dementia is the loss of cognitive functioning, thinking, remembering, and reasoning and behavioral abilities to such an extent that it interferes with a person daily life and activities. Alzheimer's disease is currently ranked as the sixth leading cause of death in the United States. The causes of dementia can vary, depending on the types of brain changes that may be taking place. Other dementias include Lewy body dementia, frontotemporal disorders, and vascular dementia. It is common for people to have mixed dementia a combination of two or more disorders, at least one of which is dementia. Alzheimer's disease is a chronic neurodegenerative disease that usually starts slowly and worsens over time which is caused by 60–70% of cases of dementia.

Cognitive Science Conferences | Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Brain Conferences

8th International Conference on Cognitive Science, Brain Disorders and Research, September 21-22, 2018 Philadelphia, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan, 6^th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark | 26^th European Neurology Congress; August 6-8, 2018; Madrid, Spain  | 4^th International Conference on Epilepsy & Treatment; August 29-30, 2018; Zurich, Switzerland |19^th Congress of the International Headache Society September 6-9, 2018; Dublin, Ireland | 22^nd International Congress of Parkinson's Disease and Movement Disorders; October 5-9, 2018; Hong Kong.

Track 10: Neurosurgery and Central Nervous System

The central nervous system is the part of the nervous system consisting of the brain and spinal cord. The central nervous system is so named because it integrates information it receives from, and coordinates and influences the activity of, all parts of the bodies of bilaterally symmetric animals that is. Many consider the retina and the optic nerve as well as the olfactory nerves and olfactory epithelium as parts of the CNS, synapsing directly on brain tissue without intermediate ganglia. The CNS is contained within the dorsal body cavity, with the brain housed in the cranial cavity and the spinal cord in the spinal canal. In vertebrates, the brain is protected by the skull, while the spinal cord is protected by the vertebrae. The brain and spinal cord are both enclosed in the meninges in central nervous systems, the intraneuronal space is filled with a large amount of supporting non-nervous cells called neuroglial cells.

Cognitive Science Conferences | Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Brain Conferences

8th International Conference on Cognitive Science, Brain Disorders and Research, September 21-22, 2018 Philadelphia, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan, 6^th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark | 26^th European Neurology Congress; August 6-8, 2018; Madrid, Spain  | 4^th International Conference on Epilepsy & Treatment; August 29-30, 2018; Zurich, Switzerland |19^th Congress of the International Headache Society September 6-9, 2018; Dublin, Ireland | 22^nd International Congress of Parkinson's Disease and Movement Disorders; October 5-9, 2018; Hong Kong

Track 11: Mental illness

Mental health includes emotional, psychological, and social well-being. It affects how we think, feel, and act. It also helps determine how we handle stress, relate to others, and make choices. Mental health is important at every stage of life, from childhood and adolescence through adulthood. Over the course of your life, if you experience mental health problems, your thinking, mood, and behavior could be affected. Many factors contribute to mental health problems, including Biological factors, such as genes or brain chemistry, Life experiences, such as trauma or abuse, Family history of mental health problems. Mental health refers to our cognitive, behavioral, and emotional wellbeing - it is all about how we think, feel, and behave. The term 'mental health' is sometimes used to mean an absence of a mental disorder

Cognitive Science Conferences | Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Brain Conferences

8th International Conference on Cognitive Science, Brain Disorders and Research, September 21-22, 2018 Philadelphia, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan, 6^th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark | 26^th European Neurology Congress; August 6-8, 2018; Madrid, Spain  | 4^th International Conference on Epilepsy & Treatment; August 29-30, 2018; Zurich, Switzerland |19^th Congress of the International Headache Society September 6-9, 2018; Dublin, Ireland | 22^nd International Congress of Parkinson's Disease and Movement Disorders; October 5-9, 2018; Hong Kong

Track 12: Mental Health Therapies

The central nervous system is the part of the nervous system consisting of the brain and spinal cord. The central nervous system is so named because it integrates information it receives from, and coordinates and influences the activity of, all parts of the bodies of bilaterally symmetric animals that is. Many consider the retina and the optic nerve as well as the olfactory nerves and olfactory epithelium as parts of the CNS, synapsing directly on brain tissue without intermediate ganglia. The CNS is contained within the dorsal body cavity, with the brain housed in the cranial cavity and the spinal cord in the spinal canal. In vertebrates, the brain is protected by the skull, while the spinal cord is protected by the vertebrae. The brain and spinal cord are both enclosed in the meninges in central nervous systems, the intraneuronal space is filled with a large amount of supporting non-nervous cells called neuroglial cells. A Neurosurgery is a physician who specializes in the diagnosis and surgical treatment of disorders of the central and peripheral nervous system including congenital anomalies, trauma, tumors, vascular disorders, infections of the brain or spine, stroke, or degenerative diseases of the spine

Cognitive Science Conferences | Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Brain Conferences

8th International Conference on Cognitive Science, Brain Disorders and Research, September 21-22, 2018 Philadelphia, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan, 6^th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark | 26^th European Neurology Congress; August 6-8, 2018; Madrid, Spain  | 4^th International Conference on Epilepsy & Treatment; August 29-30, 2018; Zurich, Switzerland |19^th Congress of the International Headache Society September 6-9, 2018; Dublin, Ireland | 22^nd International Congress of Parkinson's Disease and Movement Disorders; October 5-9, 2018; Hong Kong

Track 13: Case Reports

Clinical trials and also tending of the challenges on CNS and Neurology investigate and by taking a gander at the most lately preclinical what’s more clinical investigations. Clinical trial safety and evaluation, Improvement of clinical trial development ,Biomarkers implication in clinical trial, Clinical trial safety and evaluation ,Current challenges in translational CNS research,Improvement of clinical trial development, New approaches for the design of clinical trials, Case reports related to CNS disorders and Neurology, Remedies for CNS & Neurological Disorders. CNS Bio-markers, a chance to be they genetic traits, biochemical transforms or alterations previously, structural alternately practical features, would be needed on assistance the mixed bag of neurological disorders and to identify the progression of these diseases

Cognitive Science Conferences | Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Brain Conferences

8th International Conference on Cognitive Science, Brain Disorders and Research, September 21-22, 2018 Philadelphia, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan, 6^th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark | 26^th European Neurology Congress; August 6-8, 2018; Madrid, Spain  | 4^th International Conference on Epilepsy & Treatment; August 29-30, 2018; Zurich, Switzerland |19^th Congress of the International Headache Society September 6-9, 2018; Dublin, Ireland | 22^nd International Congress of Parkinson's Disease and Movement Disorders; October 5-9, 2018; Hong Kong

Brain Therapeutics specializes in in-licensing and commercializing approved products from Central Nervous System Sector to address the unmet medical needs of patients with Brain Disorders, such as Mood and Anxiety diseases, Schizophrenia and Bipolar Disorder, Parkinson’s and Epilepsy, as well as Pain. The team has more than 20 years’ experience within Brain Disorders and commercial capabilities acquired through years of experience in multinational pharma. In addition, the team has a strong network among CNS key opinion leaders and all these years is dedicated to Brain Disorders.

Brain Therapeutics 2019 is dedicated to the development and commercialization of critical care products with a focus on neurology, cancer care and unique prescription products using innovative, patented or proprietary formulations of previously approved active pharmaceutical ingredients By using previously approved drugs with substantial safety and efficacy data, it seeks to reduce the risks associated with pharmaceutical product development and regulatory requirements.

This report contains:

• An analysis of the trends in drug discovery and development for the neurodegenerative disorders
• An overview of the global neurological disorders treatment market which provides definitions and a structure for the industry
• Provides details for the treatment markets of specific diseases such as Alzheimer's, amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, muscular dystrophy, and other, rarer neurological disorders
• Offers a detailed analysis of patents as well as important technological developments
• A review of government regulations
• Profiles the most important companies in the industry today.

Why Tokyo??

Tourist attraction:

The Imperial Palace, Ginza District, Asakusa, and the Sensō-Ji Temple, National Museum of Nature and Science, Ueno Park and Zoo, Tokyo National Museum, National Museum of Western Art, The Meiji Shrine, The Miraikan and Edo-Tokyo Museums, The Tokyo Skytree, The National Art Center, The Kabuki-za Theatre.

Conference Highlights

• Neurology
• Central Nervous System      
• Neurosurgery
• Neuroimmunology
• Neurorehabilitation              
• Neuropsychiatry                   
• Neurochemistry                   
• Neuro Cardiology & Strokes     
• Neuroendocrinology
• Neuro-Ophthalmology
• Neuro-Oncology
• Neurotoxicity of Drug Abuse
• Neuromuscular and Spinal Disorders      
• Depression, Anxiety & Schizophrenia     
• Alzheimer’s, Dementia and Epilepsy
• Progress in Neurology         
• Mental Health and Substance Abuse      
• Meditation and Yoga            
• Neurological Disorders, Autism Spectrum Disorder, and Bipolar Disorders                                                      

Why attend???

Meet Your Target Market With members from around the world focused on learning about the latest innovations in screening and treatments for neurological disorders; this is your single best opportunity to reach the largest assemblage of participants from the Universities, Neurology research centers and hospitals and conduct demonstrations of new screening instruments, distribute information about novel agents and strategies, meet with highly affiliated speakers, showing of clinical trials as well as advancements in new neurological therapies, current methods and controversies in psychic therapy and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques for screening as well as for treatment, and the newest updates in Neurological disorders and treatments are hallmarks of this conference.

Target Audience:

•         Industry      -   21%
•         Student       -   17%
•         Academia    -   42%
•          Government - 11%
•          Others           -   9%

Major Neuroscience Societies and Associations in Tokyo

• Japan Society of Psychiatry and Neurology
• Japanese mental disorder prevention society
• Japanese Society of General Hospital Psychiatry
• Association of Japanese Clinical Psychology
• Japanese psychiatry diagnosis society
• The Japanese Society of Psychiatry and Neurology

Major Neuroscience Societies and Associations in Japan

• Japan Society of Psychiatry and Neurology
• Japanese mental disorder prevention society
• Japanese Society of General Hospital Psychiatry
• Association of Japanese Clinical Psychology
• Japanese psychiatry diagnosis society
• The Japanese Society of Psychiatry and Neurology

Societies Associated with Neurological Research

• Mental health Association in Maryland
• Society for Mental Health Research
• American Academy of Child and Adolescent Psychiatry
• Australian Clinical Psychology Association
• American Association of Neurological Surgeons
• World Psychiatry Association
• American Psychiatric Association
• European Psychiatric Association

Members Associated with Neurological Research

• Neurologists
• Psychologists
• Neurosurgeons
• Neuro Researchers
• Students
• Neuro Engineers

Top Neuroscience Universities in Japan

• Aino University
• Osaka Kawasaki Rehabilitation University
• Hagoromo International University
• Osaka University of Human Sciences
• Hannan University
• Soai University
• Heian Jogakuin-St. Agnes'-University
• Tokiwakai Gakuen University
• Kansai Medical University
• Osaka University
• Kinki University
• Okinawa Institute of Science and Technology
• Kwansei Gakuin University, Osaka-Umeda
• Keio University
• Morinomiya University of Medical Sciences
• Nagoya University

Top Neurology Universities in Globe

• Leiden University
• Keele University
• Plymouth University
• University of Toledo
• University of Sheffield
• University of Birmingham